Long-term denosumab therapy led to improved BMD among patients with RDs, regardless of GC usage or renal function.

The FDA has approved Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of fibromyalgia in adults.

The Food and Drug Administration has granted Fast Track designation to CELZ-201-DDT for the treatment of degenerative disc disease.

Rapid RTX infusion protocols appear to be a safe option for patients with autoimmune rheumatic diseases, potentially reducing the time spent in infusion clinics.

High continuous metabolic syndrome severity score trajectory pattern was linked to increased risk for CKD in adjusted analyses.

GLP-1 RA injectable use prevalence among adults with diabetes was 26.5% in 2024, but rates were higher in some age and racial groups.

Complete or partial renal response and lupus low disease activity state were associated with lupus nephritis relapse risk reduction.

Very or extremely bothersome symptoms are down compared with 10 years ago, but predicting symptoms remains elusive.

Certain gut bacterial taxa appear to be reciprocally linked with risk for insomnia, and the Odoribacter genus shows a causal effect.

Adolescents with HSD/hEDS showed levels of physical activity below that of their healthy peers, as well as more movement during sleep.

In MetS populations, obesity — especially class II and III — may be a key driver of DISH-related spinal changes, independent of age or sex.

Dr Samantha Philip and Dr Kathryn E Kyler discuss the impact of weight bias in healthcare and ways for physicians to be more ...